Published in Naunyn Schmiedebergs Arch Pharmacol on July 01, 1981
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol (1971) 2.08
Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. J Pharmacol Exp Ther (1972) 1.58
Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity. J Neurochem (1974) 1.37
Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc Natl Acad Sci U S A (1971) 1.30
Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues. J Neurochem (1973) 1.21
Angiotensin II in central nervous system physiology. Regul Pept (1998) 1.18
The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab (2000) 1.18
Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth Analg (2001) 1.11
Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem (1996) 1.07
Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Life Sci (1987) 1.06
Functional interactions between neuronal AT1 and AT2 receptors. Endocrinology (1997) 1.06
Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. Allergy (2008) 1.05
Angiotensin II type 2 receptor-modulated changes in potassium currents in cultured neurons. Am J Physiol (1993) 1.03
Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res (1993) 1.01
The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.00
Angiotensin II type 1 receptor mRNA levels in the brains of normotensive and spontaneously hypertensive rats. J Neurochem (1993) 1.00
Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J Neurochem (1993) 1.00
A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission. Br J Pharmacol (1979) 0.99
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur J Pharmacol (1995) 0.97
Structural and conformational relationships between the enkephalins and the opiates. Nature (1976) 0.96
Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Eur J Pharmacol (1984) 0.96
Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates. Br J Pharmacol (1973) 0.96
Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines. J Neurochem (1973) 0.95
Effect of exercise training on blood pressure in 70- to 79-yr-old men and women. Med Sci Sports Exerc (1991) 0.95
The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol. Psychopharmacology (Berl) (1979) 0.95
ANG II-mediated inhibition of neuronal delayed rectifier K+ current: role of protein kinase C-alpha. Am J Physiol Cell Physiol (2001) 0.95
Increased angiotensin II receptors in neuronal cultures from hypertensive rat brain. Am J Physiol (1984) 0.94
Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab (2005) 0.93
Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol Pharmacol (1997) 0.93
Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein. Am J Physiol (1994) 0.93
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology (Berl) (1996) 0.92
Increased angiotensin II type-1 receptor gene expression in neuronal cultures from spontaneously hypertensive rats. Endocrinology (1993) 0.92
Octopamine-sensitive adenylate cyclase in cockroach brain: effects of agonists, antagonists, and guanylyl nucleotides. Mol Pharmacol (1977) 0.91
A simple, sensitive, and economic assay for choline and acetylcholine using HPLC, an enzyme reactor, and an electrochemical detector. J Neurochem (1985) 0.91
Murine and human Langerhans cells express a functional histamine H4 receptor: modulation of cell migration and function. Allergy (2009) 0.90
Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis. Brain Res (1999) 0.90
The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.90
Presence of renin in primary neuronal and glial cells from rat brain. Brain Res (1987) 0.90
Pyoderma gangrenosum as a complication of percutaneous endoscopic gastrostomy tube insertion. J Clin Gastroenterol (1994) 0.90
Partial purification of the 5-hydroxytryptamine-reuptake system from human blood platelets using a citalopram-derived affinity resin [corrected]. Biochemistry (1990) 0.89
Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.89
Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment. Am J Physiol (1995) 0.89
Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun (1992) 0.89
Angiotensin II decreases neuronal delayed rectifier potassium current: role of calcium/calmodulin-dependent protein kinase II. J Neurophysiol (1999) 0.89
Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain (2005) 0.89
Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology (1999) 0.88
Activation of presynaptic alpha-noradrenaline receptors in rat brain by the potent dopamine-mimetic N,N-dipropyl-5,6-ADTN. Eur J Pharmacol (1980) 0.88
Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept (1998) 0.88
Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J Neurochem (1989) 0.88
Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A2 and arachidonic acid. J Neurosci (1998) 0.87
Angiotensin II stimulates norepinephrine uptake in hypothalamus-brain stem neuronal cultures. Am J Physiol (1986) 0.87
Mineralocorticoids modulate central angiotensin II receptors in rats. Brain Res (1986) 0.87
Altered norepinephrine uptake in neuronal cultures from spontaneously hypertensive rat brain. Am J Physiol (1985) 0.86
Angiotensin II type 2 receptor-mediated regulation of rat neuronal K+ channels. Circ Res (1996) 0.86
Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates. Br J Pharmacol (1974) 0.86
Angiotensin II stimulates protein phosphatase 2A activity in cultured neuronal cells via type 2 receptors in a pertussis toxin sensitive fashion. Adv Exp Med Biol (1996) 0.86
Magnesium and zinc potentiate ethanol inhibition of N-methyl-D-aspartate-stimulated nitric oxide synthase in cortical neurons. J Pharmacol Exp Ther (1994) 0.85
Norepinephrine metabolism in neuronal cultures is increased by angiotensin II. Am J Physiol (1987) 0.85
A-type K+ current in neurons cultured from neonatal rat hypothalamus and brain stem: modulation by angiotensin II. J Neurophysiol (1997) 0.85
Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid. J Neurophysiol (2000) 0.85
The influence of angiotensin II on catecholamine synthesis in neuronal cultures from rat brain. Biochem Biophys Res Commun (1990) 0.84
Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis. Eur J Pharmacol (1988) 0.84
Angiotensin II in neuronal cultures from brains of normotensive and hypertensive rats. Am J Physiol (1984) 0.84
Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol (1998) 0.84
On the origin of dopamine and its metabolite in predominantly noradrenergic innervated brain areas. Brain Res (1985) 0.84
Release of immunoreactive angiotensin II from neuronal cultures: adrenergic influences. Am J Physiol (1989) 0.83
On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett (1989) 0.83
Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues. J Med Chem (1986) 0.83
Penile thrombophlebitis as a presenting manifestation of pancreatic carcinoma. Am J Gastroenterol (1985) 0.83
Octopamine in mammalian brain: rapid post mortem increase and effects of drugs. J Neurochem (1976) 0.83
Automated brain dialysis of acetylcholine in freely moving rats: detection of basal acetylcholine. Life Sci (1987) 0.83
Modulation of net outward current in cultured neurons by angiotensin II: involvement of AT1 and AT2 receptors. Brain Res (1992) 0.83
Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity. J Med Chem (1996) 0.83
Modulation of K+ and Ca2+ currents in cultured neurons by an angiotensin II type 1a receptor peptide. Am J Physiol (1997) 0.83
Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. Brain Res (1997) 0.83
Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur J Pharmacol (1993) 0.83
AT1 receptors and angiotensin actions in the brain and neuronal cultures of normotensive and hypertensive rats. Adv Exp Med Biol (1995) 0.82
Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology (2001) 0.82
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.82
Decreased alpha 1-adrenergic receptor-mediated inositide hydrolysis in neurons from hypertensive rat brain. Am J Physiol (1986) 0.82
Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.82
Catecholamine-angiotensin II receptor interaction in primary cultures of rat brain. Am J Physiol (1984) 0.82
Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets. Biochem Pharmacol (1988) 0.82
Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907]. J Pharmacol Exp Ther (2004) 0.82
Autoradiographic localization of dopamine D2 receptors in the rat brain using the new agonist [3H]N-0437. Neurosci Lett (1987) 0.82
Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
Angiotensin-II induction of plasminogen activator inhibitor-1 gene expression in astroglial cells of normotensive and spontaneously hypertensive rat brain. Mol Endocrinol (1992) 0.82
Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437. Eur J Pharmacol (1989) 0.82
Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats. J Hypertens (1987) 0.82
On the origin of extracellular GABA collected by brain microdialysis and assayed by a simplified on-line method. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.82
Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices. Eur J Pharmacol (1980) 0.81
Microdialysis reveals dynamics of coupling between noradrenaline release and melatonin secretion in conscious rats. Neurosci Lett (1996) 0.81
Glucocorticoids potentiate the dipsogenic action of angiotensin II. Brain Res (1989) 0.81